Evidence map›Paper›PMID 32895188›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2020

[Application of 3D visualization and 3D printing in individualized precision surgery for Bismuth-Corlette type Ⅲ and Ⅳ hilar cholangiocarcinoma].

Ning Zeng, Jian Yang, Nan Xiang, Sai Wen, Silüe Zeng, Shuo Qi, Wen Zhu, Haoyu Hu, Chihua Fang

Open access · greenAbstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Utilization of 3D printing technology in hepatopancreatobiliary surgery.Journal of Zhejiang University. Science. B · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ning ZengFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Jian YangFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Nan XiangFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Sai WenFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Silüe ZengFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Shuo QiFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Wen ZhuFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Haoyu HuFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Chihua FangFirst Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University//Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou 510282, China.
Zhujiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the application of 3D visualization and 3D printing in individualized precision surgical treatment of Bismuth-Corlette type Ⅲ and Ⅳ hilar cholangiocarcinoma.

methodsWe retrospectively analyzed the data of 10 patients with hilar cholangiocarcinoma undergoing surgeries under the guidance of 3D visualization and 3D printing in the Department of Hepatobiliary Surgery, Zhujiang Hospital from May 2016 to March 2019. Thin-section CT data of the patients were collected for 3D reconstruction and 3D printing, and the 3D printed models were used for observing the 3D relationship of tumor with the intrahepatic bile duct, hepatic artery, portal vein and hepatic vein system and for performing preoperative simulated surgery and surgical planning. The 3D printed models were subsequently used for real-time intraoperative navigation to guide surgeries in the operating room.

results3D visualization models were successfully reconstructed for all the 10 patients and printed into 3D models. The 3D visualization types in Bismuth-Corlette classification included type Ⅲa (4 cases), type Ⅲb (4 cases), and type Ⅳ (2 cases); 4 patients showed portal vein variation, 3 had hepatic artery variation, and 2 had both portal vein and hepatic artery variations. Two patients were found to have trifurcation type of portal vein variation, one had "I-shaped" variation, and one showed the absence of the right anterior branch of the portal vein; 3 patients had hepatic artery variations with the left hepatic artery originating from the left gastric artery (1 case) and the right hepatic artery originating from the superior mesenteric artery (2 cases). Four patients with type Ⅲb underwent left hepatectomy; 4 with type Ⅲa received right hepatectomy; 1 patient with of type Ⅳ received peripheral hepatic resection and another underwent left hepatectomy. The results of preoperative 3D reconstruction, 3D printed model and preoperative planning were consistent with the intraoperative findings. The operative time was 452±75.12 min with a mean intraoperative blood loss of 356±62.35 mL and a mean hospital stay of 15 ± 4.61 days in these cases. One patient had bile leakage and 3 patients had pleural effusion postoperatively, and they were discharged after drainage and medications. No liver failure or death occurred in these cases perioperatively.

conclusions3D visualization and 3D printing can facilitate accurate preoperative assessment, surgical planning and surgical procedure optimization for Bismuth-Corlette type Ⅲ and Ⅳ hilar cholangiocarcinoma to improve surgical safety and reduce surgical risks especially in cases of intrahepatic vascular variations.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaKlatskin TumorBismuthHepatectomyHumansImaging, Three-DimensionalLiver NeoplasmsPortal VeinPrinting, Three-DimensionalRetrospective StudiesBismuthhepatectomyhilar cholangiocarcinomasurgical planningthree-dimensional printingthree-dimensional visualization

Identifiers

PMID32895188
PMCPMC7429168
OpenAlexW3084107055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.